Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of... see more

TSXV:ENTG - Post Discussion

Entourage Health Corp > WeedMD, on Sedar March 8, 2021 page 14
View:
Post by HappyFlowers25 on Mar 23, 2021 2:54pm

WeedMD, on Sedar March 8, 2021 page 14

---------Other Planned Expenditures------------ In addition to the amounts that will be allocated to achieve the milestones set out above, the Company has $ 12.7 million of commitments and approximately payments (excluding lease obligations which are $ 1.72 million for 2021) that come due in 2021 ($ 11.9 million in 2022). The Company believes such commitments can be serviced with working capital generated by the business of the Company over such time periods. The Company does not anticipate having to use any of the net proceeds towards the satisfaction of such commitments. As at January 31, 2021 the Company had a cash balance of approximately $ 18 million and working capital of approximately $ 62 million, comprised of cash (approximately $ 18 million), inventory and biological assets (approximately $ 48 million), receivables ($ 9 million) and other assets, offset by approximately $ 15 million in current liabilities. The Company expects it will be able to continue operations indefinitely using its currently available resources and the net proceeds of the Offering.
Comment by Nicksonsnowboar on Mar 24, 2021 10:45am
So that why its on a tear today